Splash Beverage Group Acquires Exclusive Global Rights to CannEpil®, an Epilepsy Therapy with Established European Patient Access, FDA Engagement and U.S. Development Potential

Detailed price information for Splash Beverage Group Inc (SBEV-A) from The Globe and Mail including charting and trades.

Argent BioPharma executes CannEpil global licensing deal

Argent to retain ownership of existing and future CannEpil IP and receive 15% royalty on Splash Beverage global CannEpil ...

Closing Bell: Market sentiment turns bitter on World Chocolate Day

The market had a bitter pill to swallow this World Chocolate Day, falling 0.31% by trade’s end on sliding commodity prices.

Gold Digger: Gold roars back as critical reporting season looms

Gold miners pulled their damn fingers out, with the sub-index for Aussie players running a bonkers 7.5% in a day as prices rose 3% to almost US$4200/oz.

Kroger chairman shifts status as two directors retire and one joins the board

Preview this article 1 min Kroger’s board went through a bit of a shakeup June 25 when it held its annual shareholders ...

Lunch Wrap: ASX slips as Coles and Woolies head to the discount bin

It’s looking like a mop and bucket kind of day, after Coles (ASX:COL) lost its footing and took the rest of the S&P/ASX 200 ...